Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Mylan Pharmaceuticals is recalling 8,679 bottles of Loxapine Capsules 25 mg due to CGMP deviations. The product was distributed throughout the United States and Puerto Rico.
Mylan Pharmaceuticals is voluntarily recalling 11,650 bottles of Loxapine Capsules 50 mg due to Current Good Manufacturing Practice (CGMP) deviations.
Milbar Laboratories is recalling 1,348 bottles of Zoma Shampoo because the product was found to be subpotent.
Mylan Institutional, Inc. is recalling Loxapine Capsules 50 mg due to cGMP violations that create a risk of cross-contamination.
Mylan Pharmaceuticals Inc. is voluntarily recalling PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets due to CGMP deviations.
Mylan Pharmaceuticals is voluntarily recalling specific lots of Prednisolone Sodium Phosphate tablets due to Current Good Manufacturing Practice (CGMP) deviations.
Lupin Pharmaceuticals is recalling My Way emergency contraception tablets because the 2-pack configuration was marketed without the required regulatory approval.
Lupin Pharmaceuticals is recalling My Way (levonorgestrel) emergency contraception tablets because the 2-pack configuration was marketed without an approved New Drug Application.
Exela Pharma Sciences LLC is recalling 5,256 bottles of Diclofenac Sodium and Misoprostol tablets because some bottles were mislabeled with the wrong dosage.
Mylan Pharmaceuticals is voluntarily recalling specific lots of Prednisolone Sodium Phosphate Orally Disintegrating Tablets due to Current Good Manufacturing Practice (CGMP) deviations.
Milbar Laboratories is voluntarily recalling 952 bottles of T Shampoo For Hair and Body because the product is subpotent.
Teva Pharmaceuticals USA is recalling Lidocaine Patch 5% products because they failed stability specifications. The recall covers 30,382 patches distributed in the United States.
Apotex Inc. is recalling 121,693 vials of Piperacillin and Tazobactam for Injection due to high impurity levels that decreased the drug's potency.
AuroMedics Pharma LLC is recalling 77,400 vials of Piperacillin and Tazobactam for Injection due to confirmed visible glass particulate matter.
Milbar Laboratories is recalling 3,477 bottles of B Prox 10 Anti-blemish Wash due to microbial contamination. Consumers should stop using the product and return it to the point of purchase.
Apotex Inc. is recalling specific lots of Piperacillin and Tazobactam for Injection due to high impurity levels that decreased the drug's potency.
L. Perrigo is recalling 569,520 cartons of Scopolamine Transdermal System nationwide due to a defective delivery system.
Prescript Pharmaceuticals is recalling Chlorhexidine 0.12% liquid due to a storage temperature labeling discrepancy. The product was distributed in California.
Prescript Pharmaceuticals is recalling Clindamycin 300 mg capsules because the storage temperature label differs from the manufacturer's original declaration.
Milbar Laboratories is voluntarily recalling 14,491 tubes of MD Complete Clarifying Cleanser due to Good Manufacturing Practice (GMP) deviations.
Mylan Pharmaceuticals is recalling Amlodipine and Benazapril HCL Capsules because cleaning processes for manufacturing equipment were not followed according to procedure.
Milbar Laboratories is recalling 2,156 tubes of Solar Defense Sheer Sunscreen SPF50 due to Good Manufacturing Practice (GMP) deviations.
Prescript Pharmaceuticals is recalling specific lots of Acetaminophen and Codeine Phosphate tablets because the storage temperature instructions on the label differ from the original manufacturer's declaration.
Sun Pharmaceutical Industries is recalling one lot of Sulfamethoxazole and Trimethoprim tablets because polyethylene was detected in two tablets.
Milbar Laboratories is recalling 4,815 tubes of Naturmetic SPF 50 Sunscreen due to Good Manufacturing Practice (GMP) deviations.